S&P 500 Futures
(0.16%) 5 335.75 points
Dow Jones Futures
(0.07%) 40 165 points
Nasdaq Futures
(0.24%) 18 681 points
Oil
(-0.54%) $79.63
Gas
(2.13%) $2.68
Gold
(0.36%) $2 426.20
Silver
(0.55%) $31.43
Platinum
(-1.53%) $1 073.30
USD/EUR
(0.09%) $0.921
USD/NOK
(0.13%) $10.69
USD/GBP
(0.06%) $0.788
USD/RUB
(-0.34%) $90.66

Realtime updates for Kancera AB (publ) [KAN.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated20 May 2024 @ 08:19

0.82% SEK 1.724

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 08:19):

Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer...

Stats
Today's Volume 168 515
Average Volume 474 319
Market Cap 208.92M
EPS SEK0 ( 2024-05-17 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -2.27
ATR14 SEK0.00900 (0.53%)

Volume Correlation

Long: -0.08 (neutral)
Short: 0.23 (neutral)
Signal:(43.936) Neutral

Kancera AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kancera AB (publ) Correlation - Currency/Commodity

The country flag -0.64
( weak negative )
The country flag -0.58
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.71
( moderate negative )
The country flag 0.00
( neutral )
The country flag 0.52
( weak )

Kancera AB (publ) Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK-3.00M (0.00 %)
EPS: SEK-0.800
FY 2023
Revenue: SEK0
Gross Profit: SEK-3.00M (0.00 %)
EPS: SEK-0.800
FY 2022
Revenue: SEK753 000
Gross Profit: SEK393 000 (52.19 %)
EPS: SEK-0.880

Financial Reports:

No articles found.

Kancera AB (publ) Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Kancera AB (publ)

Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators